On April 1, 2026, new RCEP-related origin certificate data signaled a policy-driven impact on tissue converting equipment exports, particularly for eligible fully automatic rewinding, slitting, and packaging lines shipped to Vietnam and Thailand, as zero-tariff treatment and the approved exporter self-declaration model may accelerate customs clearance.

Confirmed RCEP Certificate Developments

According to data from the China Council for the Promotion of International Trade, the issued value of certificates of origin under RCEP increased by 22.2% year on year in April 2026.

Within that certificate activity, export certificates for tissue converting equipment shipped to Vietnam and Thailand accounted for 37%.

Under the RCEP arrangements between China and Vietnam, and between China and Thailand, eligible fully automatic tissue rewinding, slitting, and packaging integrated production lines may qualify for zero-tariff treatment.

The approved exporter self-declaration model has also been put into use for eligible exporters, with customs clearance time shortened to within 48 hours according to the provided event summary.

How the Rule Shift May Affect Market Participants

Exporters engaged in direct trade

From an industry perspective, direct exporters are affected because tariff treatment and origin documentation are closely tied to quotation, contract execution, and customs clearance. For exporters of eligible tissue converting production lines, the zero-tariff condition may influence landed cost calculations, delivery commitments, and customer communication in Vietnam and Thailand.

These companies may need to pay closer attention to whether their equipment configurations, origin documentation, and exporter status support the use of RCEP preferences and the approved exporter self-declaration process.

Companies purchasing materials and components

Analysis shows that material and component buyers may be indirectly affected because origin qualification depends on whether the exported equipment meets applicable origin requirements. Procurement teams may therefore need to review component sourcing records, supplier documentation, and traceability materials more carefully.

The impact is likely to appear in bill-of-materials management, supplier confirmation, and documentation preparation before shipment. What deserves closer attention is whether procurement changes could affect the ability to support origin claims for eligible production lines.

Manufacturers of tissue converting lines

Manufacturing companies are affected because fully automatic rewinding, slitting, and packaging integrated lines are specifically connected with the reported zero-tariff opportunity. From an industry perspective, manufacturers may need stronger coordination between engineering, production, sales, and export compliance teams.

The impact may appear in specification confirmation, product classification support, technical documentation, and production scheduling. Manufacturers may also need to ensure that the delivered equipment matches the documents used for origin declaration and customs clearance.

Supply chain service providers

Supply chain service providers may be affected because shorter clearance timelines place higher pressure on document accuracy and pre-shipment preparation. Freight forwarders, customs service providers, and trade documentation partners may need to align earlier with exporters on RCEP certificate use and approved exporter declarations.

Key operational changes may involve customs document checks, shipment timing, declaration coordination, and communication with buyers in Vietnam and Thailand. Observably, faster clearance is valuable only when supporting documents are complete and consistent.

Practical Priorities for Companies

Verify origin eligibility before quoting

Companies should not treat zero-tariff access as automatic. The provided information refers to eligible fully automatic tissue rewinding, slitting, and packaging integrated production lines. Before issuing quotations or delivery promises, exporters should review whether the product scope, configuration, and origin materials support the intended RCEP treatment.

Prepare documentation for the approved exporter model

The approved exporter self-declaration model can shorten clearance time, but it also increases the importance of internal compliance control. Exporters should maintain consistent product descriptions, origin records, shipment documents, and customer-facing declarations so that customs clearance within 48 hours remains operationally feasible.

Align technical specifications with buyer requirements

For tissue converting equipment sold to Vietnam and Thailand, technical specification alignment may become more important during contract negotiation. Equipment descriptions used in commercial contracts, technical proposals, packing documents, and origin declarations should be consistent, especially for integrated production lines covering rewinding, slitting, and packaging functions.

Review delivery planning around faster clearance

If customs clearance can be shortened to within 48 hours, delivery planning may need to be adjusted. Exporters and buyers should coordinate production completion, shipping schedules, customs documentation, and installation preparation more closely. The benefit of faster clearance may be reduced if upstream documentation or equipment readiness lags behind.

Industry View: Compliance Becomes a Competitive Factor

Analysis shows that the reported increase in RCEP certificate value reflects stronger use of preferential trade arrangements, but it should be understood as a compliance-enabled opportunity rather than a guaranteed market outcome.

From an industry perspective, the most important change is not only the zero-tariff possibility, but also the link between origin qualification, exporter authorization, and clearance efficiency. Companies able to manage technical documents, origin records, and shipment declarations consistently may gain an operational advantage in cross-border equipment transactions.

It is more appropriate to understand this development as a signal that trade rules are becoming part of equipment competitiveness. For tissue converting machinery suppliers, product performance remains important, but customs readiness, documentation accuracy, and supplier traceability may increasingly influence buyer decisions.

What deserves closer attention is whether future tender documents, buyer qualification checks, or import procedures in Vietnam and Thailand place greater emphasis on RCEP documentation and approved exporter declarations. This remains an observation, not a confirmed regulatory change beyond the information provided.

Measured Outlook

The reported 22.2% year-on-year increase in RCEP certificate value and the 37% share linked to tissue converting equipment exports to Vietnam and Thailand indicate that preferential trade rules are becoming more relevant to this equipment segment.

For eligible fully automatic tissue rewinding, slitting, and packaging integrated lines, zero-tariff treatment and faster clearance may improve transaction efficiency. However, the practical impact will depend on accurate origin qualification, compliant documentation, and coordination among exporters, manufacturers, buyers, and supply chain service providers.

Source Note and Items to Monitor

This article is based on the provided news title, event date, and event summary. Relevant source types for this kind of development may include trade promotion authority data, RCEP origin rule guidance, customs clearance requirements, and official implementation notices.

Specific official source links were not provided in the input and should be verified continuously.

Further monitoring is needed for detailed policy implementation, certification review practices, approved exporter requirements, changes in tender documents, customs interpretation, and feedback from industry participants involved in tissue converting equipment exports.